SMAD3 and Peritoneal Fibrosis: In the animal model of peritoneal fibrosis, CG injury to the peritoneum resulted in increased expression of TGF‐β1 and phosphorylation (activation) of Smad3; nintedanib administration largely inhibited these responses (Figure 5A‐C).